Replies to post #185644 on Biotech Values

[DewDiligence]

ENTA management was a big disappointment.

In that case, I want to invest in more companies with disappointing management teams!

ENTA has not raised money by selling shares since inking the HCV collaboration with ABBV (then Abbott) in 2006. How many pre-commercial biotech companies have been able to go nine years without raising capital?